HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, D. M. Articles by Levy-Wilson, B. Search for Related Content PubMed PubMed Citation Articles by Wang, D. M. Articles by Levy-Wilson, B. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 2117-2124, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Evaluation of the function of the human apolipoprotein B gene nuclear matrix association regions in transgenic mice

DM Wang, S Taylor and B Levy-Wilson
Palo Alto Medical Foundation Research Institute, CA 94301, USA.

The human apolipoprotein B (apoB) gene resides in a 47.5 kb DNasel- sensitive chromosomal domain in hepatic and intestinal cells, flanked by the 5' distal matrix association region (MAR) and the 3' proximal MAR. A third MAR, the 5' proximal MAR, is found only in transcriptionally active hepatic (HepG2) cells. Hepatic expression of the apoB gene requires a tissue-specific promoter (-898 to +121) and an enhancer from the second intron of the gene (+360 to +1064). A vector containing this portion of the gene linked to the beta-galactosidase reporter is sufficient for low level expression in the livers of transgenic mice. Expression in transgenic mice was increased when the promoter-enhancer beta-gal vector was flanked by MARs. The results were similar whether the 5' distal, the 5' proximal or the 3' proximal MARs were placed at both ends of the construct, or whether the construct was flanked by the 5' distal and the 3' MAR, suggesting that the apoB MARs play a role in gene expression in vivo. When the MAR-containing constructs were transiently transfected into HepG2 cells, the resulting beta-gal activities were similar to that of the construct lacking MARs, thus demonstrating that the MARs do not exhibit any enhancer activity. Recent experiments (Kalos, M., and R. E. K. Fournier. 1995. Mol. Cell. Biol. 15: 198-207) examining stable integration of some of our constructs into human and rat hepatoma transfectants suggest that in single and double copy transfectants, the apoB MARs behave as boundary "insulators", protecting the integrated transgenes against position effects regardless of their site of integration. However, multicopy transfectants are transcriptionally inactive and when the MARs are absent, expression of the transgenes drops to background levels. Our results to date with single and low-copy number transgenes do not support an insulator function for the apoB MARs, although they appear to be required to increase the levels of expression.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. M. Gombert, S. D. Farris, E. D. Rubio, K. M. Morey-Rosler, W. H. Schubach, and A. Krumm The c-myc Insulator Element and Matrix Attachment Regions Define the c-myc Chromosomal Domain Mol. Cell. Biol., December 15, 2003; 23(24): 9338 - 9348. [Abstract] [Full Text] [PDF]

				A. MacKenzie and J. Quinn A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo PNAS, December 21, 1999; 96(26): 15251 - 15255. [Abstract] [Full Text] [PDF]

				T. J. Antes, J. Chen, A. D. Cooper, and B. Levy-Wilson The Nuclear Matrix Protein CDP Represses Hepatic Transcription of the Human Cholesterol-7alpha Hydroxylase Gene J. Biol. Chem., August 18, 2000; 275(34): 26649 - 26660. [Abstract] [Full Text] [PDF]

				J. M. Woynarowski, A. V. Trevino, K. A. Rodriguez, S. C. Hardies, and C. J. Benham AT-rich Islands in Genomic DNA as a Novel Target for AT-specific DNA-reactive Antitumor Drugs J. Biol. Chem., October 26, 2001; 276(44): 40555 - 40566. [Abstract] [Full Text] [PDF]